Welcome to LookChem.com Sign In|Join Free
  • or
(S)-2,3-bis(tert-butyldimethylsilyloxy)propyl 4-methoxybenzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1174892-40-0

Post Buying Request

1174892-40-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1174892-40-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1174892-40-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,4,8,9 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1174892-40:
(9*1)+(8*1)+(7*7)+(6*4)+(5*8)+(4*9)+(3*2)+(2*4)+(1*0)=180
180 % 10 = 0
So 1174892-40-0 is a valid CAS Registry Number.

1174892-40-0Relevant academic research and scientific papers

Stereoselective synthesis of anti-N-protected 3-amino-1,2-epoxides by nucleophilic addition to N-tert-butanesulfinyl imine of a glyceraldehyde synthon

Harried, Scott S.,Croghan, Michael D.,Kaller, Matthew R.,Lopez, Patricia,Zhong, Wenge,Hungate, Randall,Reider, Paul J.

experimental part, p. 5975 - 5982 (2009/12/24)

(Chemical Equation Presented) A di-O-TBS protected glyceraldehyde synthon was condensed with Ellman's reagent to form a bench-stable N-tert-butanesulfinyl imine 6, which served as a common intermediate for the stereoselective introduction of various R groups. The Ellman adducts were converted to useful multifunctional intermediates 18a-i in one pot. The alcohols 18a-i were efficiently elaborated to both known and novel anti-N-protected-3-amino-1,2- epoxides in two steps. Compound 2a is a key intermediate toward HIV protease inhibitors.

BETA-SECRETASE MODULATORS AND METHODS OF USE

-

Page/Page column 114, (2010/11/27)

The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein A, B, W, R3, R4, R5, i and j are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula (I), methods of use for these compounds, including treatment of AD and related diseases, by administering the compound(s) of Formula (I), or compositions including them, to a subject. The invention also comprises further embodiments of Formulas (II) and (III), intermediates and processes useful for the preparation of compounds of the invention.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1174892-40-0